- Consolidated revenue of €4.725 billion, up +4.3% at constant rates (+0.8% at current rates)

- Revenue for brand-name medicines of €3.306 billion +4.8% at constant rates (+0.6% at current rates) and €1.419 billion for the generics +2.9% at constant rates (+1.1% at current rates)

- An accelerated oncology strategy with the...